Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• Cancer stem cells (CSCs) possess self-renewal and metastatic capabilities, contributing to treatment resistance and cancer recurrence.
• CSCs are a unique subset of tumor cells resilient to conventional therapies like radiotherapy and chemotherapy.

Purpose of the Study:

• To explore novel research avenues into CSC characteristics within the tumor microenvironment (TME).
• To examine CSC interactions with lymphoid, myeloid, and mesenchymal cells, and the extracellular matrix (ECM).
• To highlight therapeutic strategies targeting CSCs in the TME for improved cancer immunotherapy.

Main Methods:

• Review of existing literature on CSC biology and TME interactions.
• Analysis of CSC crosstalk with various immune and stromal cell types.
• Examination of pre-clinical and clinical studies on CSC-targeting therapies.

Main Results:

• CSCs exhibit complex interactions with diverse cellular components of the TME, including immune cells and fibroblasts.
• The tumor microenvironment significantly influences CSC behavior and therapeutic resistance.
• Emerging therapies like CAR-T, oncolytic viruses, and CSC-vaccines show promise for CSC-based immunotherapy.

Conclusions:

• Understanding CSCs within the TME is crucial for overcoming treatment resistance.
• Targeting CSC-TME interactions offers potential for novel cancer immunotherapy strategies.
• Further research into CSC-based therapies is warranted to improve patient outcomes.